RadNet Net Income 2010-2023 | RDNT

RadNet net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
RadNet Annual Net Income
(Millions of US $)
2023 $3
2022 $11
2021 $25
2020 $-15
2019 $15
2018 $32
2017 $0
2016 $7
2015 $8
2014 $1
2013 $2
2012 $60
2011 $7
2010 $-13
2009 $-2
RadNet Quarterly Net Income
(Millions of US $)
2023-12-31 $-2
2023-09-30 $18
2023-06-30 $8
2023-03-31 $-21
2022-12-31 $-1
2022-09-30 $1
2022-06-30 $8
2022-03-31 $3
2021-12-31 $-4
2021-09-30 $16
2021-06-30 $3
2021-03-31 $9
2020-12-31 $6
2020-09-30 $6
2020-06-30 $-11
2020-03-31 $-16
2019-12-31 $10
2019-09-30 $3
2019-06-30 $5
2019-03-31 $-4
2018-12-31 $29
2018-09-30 $5
2018-06-30 $5
2018-03-31 $-7
2017-12-31 $-7
2017-09-30 $3
2017-06-30 $5
2017-03-31 $-1
2016-12-31 $3
2016-09-30 $2
2016-06-30 $4
2016-03-31 $-1
2015-12-31 $1
2015-09-30 $8
2015-06-30 $3
2015-03-31 $-5
2014-12-31 $4
2014-09-30 $4
2014-06-30 $5
2014-03-31 $-12
2013-12-31 $1
2013-09-30 $-0
2013-06-30 $3
2013-03-31 $-1
2012-12-31 $52
2012-09-30 $5
2012-06-30 $3
2012-03-31 $-0
2011-12-31 $5
2011-09-30 $0
2011-06-30 $4
2011-03-31 $-1
2010-12-31 $3
2010-09-30 $-0
2010-06-30 $-12
2010-03-31 $-4
2009-12-31 $1
2009-09-30 $-2
2009-06-30 $-0
2009-03-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.279B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $15.906B 9.62
Quest Diagnostics (DGX) United States $14.151B 14.63
DaVita (DVA) United States $11.382B 15.49
Chemed (CHE) United States $9.221B 29.02
Encompass Health (EHC) United States $8.008B 21.97
Elanco Animal Health (ELAN) United States $6.724B 15.33
Option Care Health (OPCH) United States $5.444B 21.31
Amedisys (AMED) United States $2.981B 21.27
LifeStance Health (LFST) United States $2.139B 0.00
Astrana Health (ASTH) United States $2.100B 26.50
Addus HomeCare (ADUS) United States $1.574B 24.13
U.S Physical Therapy (USPH) United States $1.495B 38.76
Pennant (PNTG) United States $0.608B 35.10
Aveanna Healthcare Holdings (AVAH) United States $0.439B 0.00
Atai Life Sciences (ATAI) Germany $0.357B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00